Trial · NCT00445341
Adverse events121
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 121
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ALT, SGPT (serum glutamic pyruvic transaminase) | Metabolism and nutrition disorders | Flavopiridol in Lymphoma Patients | 13 | 28 | 47 |
| other | AST, SGOT(serum glutamic oxaloacetic transaminase) | Metabolism and nutrition disorders | Flavopiridol in Lymphoma Patients | 22 | 28 | 84 |
| other | Albumin, serum-low (hypoalbuminemia) | Metabolism and nutrition disorders | Flavopiridol in Lymphoma Patients | 23 | 28 | 136 |
| other | Alkaline phosphatase | Metabolism and nutrition disorders | Flavopiridol in Lymphoma Patients | 16 | 28 | 33 |
| other | Allergic reaction/hypersensitivity (including drug fever) | Immune system disorders | Flavopiridol in Lymphoma Patients | 1 | 28 | 1 |
| other | Allergic rhinitis (including sneezing, nasal stuffiness, postnasal drip) | Immune system disorders | Flavopiridol in Lymphoma Patients | 1 | 28 | 1 |
| other | Anorexia | Gastrointestinal disorders | Flavopiridol in Lymphoma Patients | 8 | 28 | 8 |
| other | Bicarbonate, serum-low | Metabolism and nutrition disorders | Flavopiridol in Lymphoma Patients | 9 | 28 | 13 |
| other | Bilirubin (hyperbilirubinemia) | Metabolism and nutrition disorders | Flavopiridol in Lymphoma Patients | 12 | 28 | 31 |
| other | CPK (creatine phosphokinase) | Metabolism and nutrition disorders | Flavopiridol in Lymphoma Patients | 4 | 28 | 6 |
| other | Calcium, serum-high (hypercalcemia) | Metabolism and nutrition disorders | Flavopiridol in Lymphoma Patients | 4 | 28 | 15 |
| other | Calcium, serum-low (hypocalcemia) | Metabolism and nutrition disorders | Flavopiridol in Lymphoma Patients | 9 | 28 | 23 |
| other | Cholesterol, serum-high (hypercholesteremia) | Metabolism and nutrition disorders | Flavopiridol in Lymphoma Patients | 1 | 28 | 1 |
| other | Confusion | Nervous system disorders | Flavopiridol in Lymphoma Patients | 1 | 28 | 1 |
| other | Constipation | Gastrointestinal disorders | Flavopiridol in Lymphoma Patients | 3 | 28 | 3 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Flavopiridol in Lymphoma Patients | 2 | 28 | 2 |
| other | Creatinine | Metabolism and nutrition disorders | Flavopiridol in Lymphoma Patients | 9 | 28 | 15 |
| other | Cytokine release syndrome/acute infusion reaction | Immune system disorders | Flavopiridol in Lymphoma Patients | 1 | 28 | 1 |
| other | Dehydration | Gastrointestinal disorders | Flavopiridol in Lymphoma Patients | 2 | 28 | 2 |
| other | Diarrhea | Gastrointestinal disorders | Flavopiridol in Lymphoma Patients | 22 | 28 | 99 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00445341/events